Genix Announces TSX-V Approval of Warrant Amendments

Vancouver, British Columbia--(Newsfile Corp. - February 6, 2024) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") announces that pursuant to its news release

newsfileFeb 6 13:29 ET

Genix Announces Warrant Repricing and Seeks Extension

Vancouver, British Columbia--(Newsfile Corp. - January 18, 2024) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") announces that the Company has made an appli

newsfileJan 18 18:05 ET

Genix Announces AGM Results

Vancouver, British Columbia--(Newsfile Corp. - May 26, 2023) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") is pleased to report the results of the Annual G

newsfileMay 26, 2023 16:27 ET

Genix Receives Approval to Extend Warrants from the TSX Venture Exchange

Vancouver, British Columbia--(Newsfile Corp. - July 28, 2022) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") announces that the Company has received approva

newsfileJul 28, 2022 08:50 ET

Genix Proposes to Extend Warrants

Vancouver, British Columbia--(Newsfile Corp. - July 20, 2022) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") announces that the Company has made an applicat

newsfileJul 20, 2022 08:55 ET